Web29 Jun 2024 · Most patients require two agents to control their BP (Chobanian, 2008) and side effects are less likely when using low doses (Salaam et al, 2024). Further, a lower BP target is probably better (SPRINT 2015; Zhang, 2024). Thus, a low dose combination of two meds at 25% or 50% max dose of each agent is a good option, especially if BP is more … Web2 days ago · Skip to main content Skip to article ... Journals & Books
#343 Hypertension FAQ and Cardiorenal: A rapid review (TFTC)
WebThe Systolic Pressure Interventional Trial (SPRINT) represents an important clinical trial to inform practice in the treatment of hypertension. The trial randomized over 9,000 subjects … Web9 Nov 2015 · The multicenter Systolic Blood Pressure Intervention Trial (SPRINT) now provides some guidance. SPRINT researchers enrolled 9361 patients (age, ≥50) with systolic BP of 130 to 180 mm Hg and high cardiovascular (CV ... but treating to these BP goals is associated with important risks, including life-threatening hypotension, syncope, and … healthy pad thai
Effects of Intensive Blood Pressure Treatment on Acute Kidney …
Web30 Sep 2015 · Current clinical practice, endorsed by hypertension guidelines, is to try to lower systolic blood pressure (SBP) to less than 140 mm Hg in most patients. The recent report from the Joint National Committee (JNC 8) recommends relaxing BP goals in elderly patients to aim for SBP of less than 150 mm Hg, citing lack of evidence for more … Web28 Jan 2024 · Results of the SPRINT trial, which ended early, showed that intensive blood pressure control, i.e., a systolic blood pressure target of less than 120 mmHg (<120 mmHg), compared to a standard target of less than 140 mmHg (<140 mmHg), reduced cardiovascular events and overall mortality. Web25 Nov 2015 · SPRINT was a large randomized controlled trial with over 9,000 non-diabetic patients, funded by the NIH, to study the effect of intensive blood pressure control on cardiovascular health. The trial was terminated early (after a mean follow-up of 3.3 years) due to a significantly lower rate of the primary composite outcome (MI, ACS not resulting ... healthy page file